Germline heterozygous SH2B3‐mutations and (idiopathic) erythrocytosis: Detection of a previously undescribed mutation
Open Access
Abstract
Erythrocytosis or polycythemia refers to a true or apparent increase in hemoglobin or hematocrit. When no etiology of erythrocytosis is identified, people are diagnosed with “idiopathic erythrocytosis” (IE). The identification of new contributing genes has recently improved the diagnostic workup of IE. As such mutations within the SH2B3 gene, which codes for the LNK protein and negatively regulates the JAK‐STAT pathway, have been identified in cases diagnosed as IE. This reports describes the presence of a previously undescribed germline SH2B3 variant p.(Thr335ArgfsTer4) within IE and emphasizes the advantages of gene panel sequencing as second step in the diagnostic work‐up.Keywords
This publication has 15 references indexed in Scilit:
- A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosisBritish Journal of Haematology, 2018
- Megakaryocytes in Myeloproliferative Neoplasms Have Unique Somatic MutationsThe American Journal of Pathology, 2017
- The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disordersLeukemia, 2017
- Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutationsHaematologica, 2016
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemiaBlood, 2016
- RELN Mutations in Autism Spectrum DisorderFrontiers in Cellular Neuroscience, 2016
- Infrequent occurrence of mutations in the PH domain of LNK in patients with JAK2 mutation-negative 'idiopathic' erythrocytosisHaematologica, 2013
- LNKMutations inJAK2Mutation–Negative ErythrocytosisNew England Journal of Medicine, 2010
- LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutationsLeukemia, 2010
- Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathwaysBlood, 2005